Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 168555-66-6 | Product Number: C3009
Combretastatin A4 Phosphate Disodium Salt
Purity: >98.0%(HPLC)
- Fosbretabulin Disodium Salt
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
20MG |
$212.00
|
1 | Contact Us | 30 |
|
100MG |
$633.00
|
1 | Contact Us | 1 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | C3009 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__8H__1__9Na__2O__8P = 440.30 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 168555-66-6 |
PubChem Substance ID | 354333373 |
MDL Number | MFCD00943911 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
HS Number | 2919.90.3000 |
References
- Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs
- Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues
- Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.